{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:46:34Z","timestamp":1784547994576,"version":"3.55.0"},"reference-count":161,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T00:00:00Z","timestamp":1317081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Photoderm Photoimm Photomed"],"published-print":{"date-parts":[[2011,10]]},"abstract":"<jats:p>Vitiligo is a common skin disease characterized by loss of normal melanin pigments in the skin and its pathogenesis is still unclear. Treatment modalities include psoralen plus ultraviolet A, narrow\u2010band ultraviolet B (NB UVB) phototherapy, topical and systemic steroids, topical calcineurin inhibitors, topical vitamin D analogues in monotherapy or in association with phototherapy, and surgical treatment. NB UVB (310\u2013315\u2003nm) radiation is now considered as the \u2018gold standard\u2019 for the treatment of diffuse vitiligo, and treatment with two recently introduced UVB sources that emit 308\u2003nm wavelengths, the 308\u2003nm xenon chloride (XeCl) excimer laser and the 308\u2003nm XeCl excimer light, has also been reported to be effective and might be the treatment of choice for localized disease: this treatment modality has been defined as \u2018targeted phototherapy.\u2019<\/jats:p>","DOI":"10.1111\/j.1600-0781.2011.00606.x","type":"journal-article","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T05:14:39Z","timestamp":1317186879000},"page":"261-277","source":"Crossref","is-referenced-by-count":65,"title":["Photo(chemo)therapy for vitiligo"],"prefix":"10.1111","volume":"27","author":[{"given":"Alessia","family":"Pacifico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,9,27]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/9780470760116.ch4","volume-title":"Vitiligo","author":"Majumder M.P.","year":"2000"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2005.01369.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0749.2003.00023.x"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2005.10.001"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12492612"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0749.2006.00333.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470760116.ch18"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12480976"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0749.2007.00396.x"},{"key":"e_1_2_5_11_2","first-page":"87","article-title":"New insights into the pathogenesis of vitiligo","volume":"15","author":"Moretti S","year":"2002","journal-title":"imbalance of epidermal cytokines at sites of lesions"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908547"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.337"},{"key":"e_1_2_5_14_2","first-page":"252","article-title":"The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A","volume":"121","author":"Nijsten TE","year":"2003","journal-title":"a cohort study"},{"key":"e_1_2_5_15_2","first-page":"1041","article-title":"Malignant melanoma in patients treated for psoriasis with methoxalen (psoralen) and ultraviolet A radiation (PUVA)","volume":"336","author":"Stern RS","year":"1997","journal-title":"the PUVA follow-up study"},{"key":"e_1_2_5_16_2","first-page":"165","article-title":"Safety and therapeutic effectiveness of 8\u2010methoxypsoralen, 4,5\u2032,8\u2010trimethylpsoralen, and psoralen in vitiligo","volume":"66","author":"Pathak MA","year":"1984","journal-title":"Natl Cancer Inst Monogr"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199856040-00015"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30271-7"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630252775207"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70255-2"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(02)02926-5"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.1989.tb02917.x"},{"key":"e_1_2_5_23_2","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1001\/archderm.1997.03890480050007","article-title":"Oral psoralen with UV\u2010A therapy releases circulating growth factor(s) that stimulates cell proliferation","volume":"133","author":"Abdel\u2010Naser MB","year":"1997","journal-title":"Arch Dermatol"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07584.x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70194-X"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1981.tb15315.x"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12529859"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2001.01348.x"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00700.x"},{"key":"e_1_2_5_30_2","first-page":"104","article-title":"Psoralen photochemotherapy (PUVA) is only moderately effective in widespread vitiligo","volume":"27","author":"Kwok YKC","year":"2002","journal-title":"a 10-year retrospective study"},{"key":"e_1_2_5_31_2","first-page":"256","article-title":"Vitiligo treatment","volume":"15","author":"Ortel B","year":"1986","journal-title":"Curr Probl Dermatol"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.12.1514"},{"key":"e_1_2_5_33_2","first-page":"183","article-title":"PUVA\u2010induced phototoxicity","volume":"36","author":"Morison WL","year":"1997","journal-title":"Incidence and causes"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70148-9"},{"key":"e_1_2_5_35_2","first-page":"2759","article-title":"The carcinogenic risk of treatments for severe psoriasis","volume":"73","author":"Stern RS","year":"1994","journal-title":"photochemotherapy follow-up study"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.1999.tb00052.x"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12319764"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12085.x"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb02910.x"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)81729-X"},{"key":"e_1_2_5_41_2","first-page":"147","article-title":"Deterioration of liver function during PUVA therapy","volume":"1","author":"Freeman K","year":"1984","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"e_1_2_5_42_2","first-page":"1276","article-title":"Confetti\u2010like hypopigmentation","volume":"21","author":"Bhatnagar A","year":"2007","journal-title":"a rare complication of common phototherapeutic modality"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2008.00528.x"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90691-X"},{"key":"e_1_2_5_45_2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2340\/0001555556253256","article-title":"Oral trimethylpsoralen in the treatment of vitiligo","volume":"56","author":"Theodoridis A","year":"1976","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_5_46_2","first-page":"461","article-title":"Vitiligo","volume":"28","author":"Handa S","year":"2001","journal-title":"a retrospective comparative analysis of treatment modalities in 500 patients"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1159\/000017991"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(82)70159-8"},{"key":"e_1_2_5_49_2","first-page":"22","article-title":"Guidelines for topical PUVA","volume":"142","author":"Halpern SM","year":"2000","journal-title":"a report of a workshop of the British Photodermatology group"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1998.tb01272.x"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1159\/000249932"},{"key":"e_1_2_5_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(88)70092-4"},{"key":"e_1_2_5_53_2","doi-asserted-by":"publisher","DOI":"10.3109\/09546639509097164"},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00414110"},{"key":"e_1_2_5_55_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247142"},{"key":"e_1_2_5_56_2","first-page":"216","article-title":"Treatment of vitiligo with oral and topical phenylalanine","volume":"135","author":"Camacho F","year":"1999","journal-title":"6 years of experience"},{"key":"e_1_2_5_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001050050104"},{"key":"e_1_2_5_58_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.9.1061"},{"key":"e_1_2_5_59_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2006.00229.x"},{"key":"e_1_2_5_60_2","first-page":"1022","article-title":"Phototherapy with UV\u2010B in vitiligo","volume":"65","author":"K\u00f6ster W","year":"1990","journal-title":"Z Hautkr"},{"key":"e_1_2_5_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12520022"},{"key":"e_1_2_5_62_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1997.03890480045006"},{"key":"e_1_2_5_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90133-6"},{"key":"e_1_2_5_64_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.114752"},{"key":"e_1_2_5_65_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0781.2003.00039.x"},{"key":"e_1_2_5_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2006.00222.x"},{"key":"e_1_2_5_67_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015550410022203"},{"key":"e_1_2_5_68_2","first-page":"429","article-title":"Photoprotection in vitiligo and normal skin","volume":"76","author":"Gniadecka M","year":"1996","journal-title":"a quantitative assessment of the role of stratum corneum, viable epidermis and pigmentation"},{"key":"e_1_2_5_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2007.00311.x"},{"key":"e_1_2_5_70_2","first-page":"1","article-title":"Epidermal photoprotection","volume":"12","author":"El\u2010Khateeb EA","year":"2010","journal-title":"comparative study of narrowband ultraviolet B minimal erythema doses with and without stratum corneum stripping in normal and vitiligo skin"},{"key":"e_1_2_5_71_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2010.00510.x"},{"key":"e_1_2_5_72_2","unstructured":"PacificoA IacovelliP Paro VidolinA LeoneG.\u201cStop and go\u201d NB UVB phototherapy protocol effectiveness versus continous NB UVB protocol in the treatment of patients with vitiligo: a randomized controlled study. The 20th Annual Meeting of the Photomedicine Society 3 February 2011 New Orleans."},{"key":"e_1_2_5_73_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.1998.tb09107.x"},{"key":"e_1_2_5_74_2","doi-asserted-by":"publisher","DOI":"10.1562\/0031-8655(2002)0760397FOCPDA2.0.CO2"},{"key":"e_1_2_5_75_2","first-page":"370","article-title":"No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy","volume":"84","author":"Weischer M","year":"2004","journal-title":"a first retrospective study"},{"key":"e_1_2_5_76_2","first-page":"755","article-title":"The photocarcinogenic risk of narrowband UVB (TL\u201001) phototherapy","volume":"152","author":"Man I","year":"2005","journal-title":"early follow-up data"},{"key":"e_1_2_5_77_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07477_3.x"},{"key":"e_1_2_5_78_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08776.x"},{"key":"e_1_2_5_79_2","first-page":"1S194","article-title":"The paradox of hypopigmentation and decreased risk of skin cancer in vitiligo","volume":"129","author":"Nordlund J.","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_5_80_2","doi-asserted-by":"publisher","DOI":"10.1159\/000057881"},{"key":"e_1_2_5_81_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0625.2003.00084.x"},{"key":"e_1_2_5_82_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2006.00224.x"},{"key":"e_1_2_5_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.09.004"},{"key":"e_1_2_5_84_2","first-page":"891","article-title":"Narrowband UVB therapy for vitiligo","volume":"21","author":"Sitek JC","year":"2007","journal-title":"does the repigmentation last?"},{"key":"e_1_2_5_85_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)01484-1"},{"key":"e_1_2_5_86_2","first-page":"57","article-title":"Narrow\u2010band UVB for the treatment of vitiligo","volume":"44","author":"Kanwar AJ","year":"2005","journal-title":"an emerging effective and well-tolerated therapy"},{"key":"e_1_2_5_87_2","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.48662"},{"key":"e_1_2_5_88_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-69361-1_42"},{"key":"e_1_2_5_89_2","first-page":"1369","article-title":"Critical evaluation of the variants influencing the clinical response of vitiligo","volume":"21","author":"Brazzelli V","year":"2007","journal-title":"study of 60 cases treated with ultraviolet B narrow-band phototherapy"},{"key":"e_1_2_5_90_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12480997"},{"key":"e_1_2_5_91_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2005.tb00843.x"},{"key":"e_1_2_5_92_2","first-page":"219","article-title":"The poor response of phototherapy in old lesions of vitiligo may be related to the presence of white hairs","volume":"26","author":"Youn Lee D","year":"2010","journal-title":"a hypothesis"},{"key":"e_1_2_5_93_2","first-page":"1","article-title":"PUVA\u2010induced repigmentation of vitiligo","volume":"101","author":"Ortonne JP","year":"1979","journal-title":"a histochemical (split-DOPA) and ultrastructural study"},{"key":"e_1_2_5_94_2","first-page":"500","article-title":"White hairs in segmental vitiligo are related to poor response to phototherapy","volume":"37","author":"Youn Lee D","year":"2010","journal-title":"demonstration with portable digital microscopy"},{"key":"e_1_2_5_95_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.4.711"},{"key":"e_1_2_5_96_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0749.2003.00126.x"},{"key":"e_1_2_5_97_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0906-6705.2004.00221.x"},{"key":"e_1_2_5_98_2","first-page":"6","article-title":"Narrow band ultraviolet B 311\u2003nm in the treatment of vitiligo","volume":"22","author":"El Mofty M","year":"2006","journal-title":"two right-left comparison studies"},{"key":"e_1_2_5_99_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01413.x"},{"key":"e_1_2_5_100_2","first-page":"638","article-title":"Comparison of systemic PUVA and NB\u2010UVB in the treatment of vitiligo","volume":"21","author":"Bhatnagar A","year":"2007","journal-title":"an open prospective study"},{"key":"e_1_2_5_101_2","first-page":"578","article-title":"Randomized double\u2010blind trial of treatment of vitiligo","volume":"143","author":"Yones SS","year":"2007","journal-title":"efficacy of psoralen-UVA therapy vs narrowband UV-B therapy"},{"key":"e_1_2_5_102_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02154.x"},{"key":"e_1_2_5_103_2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2340\/000155555577460462","article-title":"Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure","volume":"77","author":"Juhlin L","year":"1997","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_5_104_2","doi-asserted-by":"publisher","DOI":"10.1080\/000155502320624113"},{"key":"e_1_2_5_105_2","first-page":"631","article-title":"Antioxidants and narrow band\u2010UVB in the treatment of vitiligo","volume":"32","author":"Dell'Anna ML","year":"2007","journal-title":"a double-blind placebo controlled study"},{"key":"e_1_2_5_106_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009335769"},{"key":"e_1_2_5_107_2","doi-asserted-by":"publisher","DOI":"10.1080\/08941930701598792"},{"key":"e_1_2_5_108_2","first-page":"942","article-title":"Treatment of vitiligo vulgaris with narrow\u2010band UVB and oral Polypodium leucotomos extract","volume":"21","author":"Middelkamp\u2010Hup MA","year":"2007","journal-title":"a randomized double-blind placebo-controlled study"},{"key":"e_1_2_5_109_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.3.393"},{"key":"e_1_2_5_110_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2004.00114.x"},{"key":"e_1_2_5_111_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01546.x"},{"key":"e_1_2_5_112_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2005.02037.x"},{"key":"e_1_2_5_113_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2005.00139.x"},{"key":"e_1_2_5_114_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2006.00079.x"},{"key":"e_1_2_5_115_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.7.927"},{"key":"e_1_2_5_116_2","first-page":"916","article-title":"Narrow\u2010band UVB phototherapy combined with tacrolimus ointment in vitiligo","volume":"21","author":"Fai D","year":"2007","journal-title":"a review of 110 patients"},{"key":"e_1_2_5_117_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2010.00540.x"},{"key":"e_1_2_5_118_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2007.00617.x"},{"key":"e_1_2_5_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2007.11.013"},{"key":"e_1_2_5_120_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12335801"},{"key":"e_1_2_5_121_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00456842"},{"key":"e_1_2_5_122_2","first-page":"223","article-title":"Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short\u2010term UVB exposure","volume":"190","author":"Schallreuter KU","year":"1995","journal-title":"a case study on 33 patients"},{"key":"e_1_2_5_123_2","first-page":"641","article-title":"Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo","volume":"27","author":"Patel DC","year":"2002","journal-title":"an open, single-centre study"},{"key":"e_1_2_5_124_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09252.x"},{"key":"e_1_2_5_125_2","first-page":"721","article-title":"Pseudocatalase and narrowband ultraviolet B for vitiligo","volume":"161","author":"Gawkrodger D.","year":"2009","journal-title":"clearing the picture"},{"key":"e_1_2_5_126_2","first-page":"7","article-title":"Study comparing a vegetal extract with superoxide dismutase and catalase activities (Vitix\u00ae) plus selective UVB phototherapy versus an excipient plus selective UVB phototherapy in the treatment of vitiligo vulgaris","volume":"23","author":"Khemis A","year":"2004","journal-title":"Nouv Dermatol"},{"key":"e_1_2_5_127_2","first-page":"10","article-title":"Treatment of vitiligo with narrow\u2010band UVB and topical gel containing catalase and superoxide dismutase","volume":"15","author":"Kostovic K","year":"2007","journal-title":"Acta Dermatovenereol Croat"},{"key":"e_1_2_5_128_2","first-page":"17","article-title":"Comparison between narrow\u2010band UVB with topical corticosteroid and narrow\u2010band UVB with placebo in the treatment of vitiligo","volume":"14","author":"Lim\u2010Ong M","year":"2005","journal-title":"a randomized controlled trial"},{"key":"e_1_2_5_129_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2010.01477.x"},{"key":"e_1_2_5_130_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12011.x"},{"key":"e_1_2_5_131_2","first-page":"2119","article-title":"Low\u2010energy helium\u2010neon laser induces locomotion of the immature melanoblasts and promotes melanogenesis of the more differentiated melanoblasts","volume":"126","author":"Lan CC","year":"2006","journal-title":"recapitulation of vitiligo repigmentation in vitro"},{"key":"e_1_2_5_132_2","first-page":"273","article-title":"Low\u2010energy helium\u2010neon laser induces melanocyte proliferation via interaction with type IV collagen","volume":"161","author":"Lan CC","year":"2009","journal-title":"visible light as a therapeutic option for vitiligo"},{"key":"e_1_2_5_133_2","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1001\/archderm.138.12.1613","article-title":"Treatment of vitiligo with the 308\u2003nm xenon chloride excimer laser","volume":"138","author":"Baltas E","year":"2002","journal-title":"Arch Dermatol"},{"key":"e_1_2_5_134_2","first-page":"727","article-title":"Treatment of vitiligo with the 308\u2003nm excimer laser","volume":"46","author":"Spencer JM","year":"2002","journal-title":"a pilot study"},{"key":"e_1_2_5_135_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01547.x"},{"key":"e_1_2_5_136_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2003.01997.x"},{"key":"e_1_2_5_137_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06321.x"},{"key":"e_1_2_5_138_2","doi-asserted-by":"publisher","DOI":"10.1089\/pho.2006.24.354"},{"key":"e_1_2_5_139_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2005.10.024"},{"key":"e_1_2_5_140_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2009.00914.x"},{"key":"e_1_2_5_141_2","first-page":"130","article-title":"Combined excimer laser and topical tacrolimus for the treatment of vitiligo","volume":"30","author":"Kawalek AZ","year":"2004","journal-title":"a pilot study"},{"key":"e_1_2_5_142_2","first-page":"1065","article-title":"Topical tacrolimus and the 308\u2010nm excimer laser","volume":"140","author":"Passeron T","year":"2004","journal-title":"a synergistic combination for the treatment of vitiligo"},{"key":"e_1_2_5_143_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08793.x"},{"key":"e_1_2_5_144_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1011-1344(02)00280-4"},{"key":"e_1_2_5_145_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.2004.tb00031.x"},{"key":"e_1_2_5_146_2","first-page":"408","article-title":"Monochromatic excimer light (308\u2003nm)","volume":"17","author":"Bianchi B","year":"2003","journal-title":"an immunohistochemical study of cutaneous T cells and apoptosis related molecules in psoriasis"},{"issue":"1","key":"e_1_2_5_147_2","first-page":"11","article-title":"308\u2003nm monochromatic excimer light for the treatment of palmoplantar psoriasis","volume":"13","author":"Campolmi P","year":"2002","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"e_1_2_5_148_2","first-page":"14","article-title":"308\u2003nm monochromatic excimer light in psoriasis","volume":"13","author":"Cappugi P","year":"2002","journal-title":"clinical evaluation and study of cytokine levels in the skin"},{"key":"e_1_2_5_149_2","first-page":"531","article-title":"Monochromatic excimer light 308\u2003nm in the treatment of vitiligo","volume":"17","author":"Leone G","year":"2003","journal-title":"a pilot study"},{"key":"e_1_2_5_150_2","first-page":"310","article-title":"Topical tacalcitol and 308\u2010nm monochromatic excimer light","volume":"22","author":"Lu\u2010yan T","year":"2006","journal-title":"a synergistic combination for the treatment of vitiligo"},{"key":"e_1_2_5_151_2","first-page":"391","article-title":"Monochromatic excimer light 308\u2003nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo","volume":"22","author":"Saraceno R","year":"2009","journal-title":"a controlled study"},{"key":"e_1_2_5_152_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2009.00396.x"},{"key":"e_1_2_5_153_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06533.x"},{"key":"e_1_2_5_154_2","first-page":"273","article-title":"Short term effects of 308\u2003nm xenon chloride excimer laser and narrow band ultraviolet B in the treatment of vitiligo","volume":"20","author":"Hong SB","year":"2005","journal-title":"a comparative study"},{"key":"e_1_2_5_155_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02151.x"},{"key":"e_1_2_5_156_2","first-page":"188","article-title":"308\u2010nm excimer lamp vs. 308\u2010nm excimer laser for treating vitiligo","volume":"163","author":"Le Duff F","year":"2010","journal-title":"a randomized study"},{"key":"e_1_2_5_157_2","first-page":"133","article-title":"Treatment of localized vitiligo with targeted broadband UVB phototherapy","volume":"22","author":"Asawanonda P","year":"2006","journal-title":"a pilot study"},{"key":"e_1_2_5_158_2","first-page":"376","article-title":"Targeted broadband ultraviolet B phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo","volume":"88","author":"Asawanonda P","year":"2008","journal-title":"a randomized, double-blind study"},{"key":"e_1_2_5_159_2","first-page":"642","article-title":"Targeted UVB phototherapy for psoriasis","volume":"232","author":"Lapidoth M","year":"2007","journal-title":"a preliminary study"},{"key":"e_1_2_5_160_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2009.03928.x"},{"key":"e_1_2_5_161_2","first-page":"171","article-title":"Narrow\u2010band UV\u2010B micro\u2010phototherapy","volume":"17","author":"Menchini G","year":"2003","journal-title":"a new treatment for vitiligo"},{"key":"e_1_2_5_162_2","first-page":"16","article-title":"Letter: Association of targeted intense pulse light system UVA1\u2010UVB and fluticasone in the treatment of vitiligo","volume":"15","author":"Coelho JD","year":"2010","journal-title":"prospective study of 10 patients"}],"container-title":["Photodermatology, Photoimmunology &amp; Photomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0781.2011.00606.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0781.2011.00606.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T23:34:19Z","timestamp":1698708859000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0781.2011.00606.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,27]]},"references-count":161,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["10.1111\/j.1600-0781.2011.00606.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0781.2011.00606.x","archive":["Portico"],"relation":{},"ISSN":["0905-4383","1600-0781"],"issn-type":[{"value":"0905-4383","type":"print"},{"value":"1600-0781","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,27]]}}}